HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delina Ferretti Selected Research

MAC combination (MAC protocol)

10/2006Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Delina Ferretti Research Topics

Disease

2Multiple Myeloma
10/2006 - 09/2004

Drug/Important Bio-Agent (IBA)

2Arsenic Trioxide (Trisenox)FDA Link
10/2006 - 09/2004
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
10/2006 - 09/2004
2Melphalan (Alkeran)FDA LinkGeneric
10/2006 - 09/2004

Therapy/Procedure

1MAC combination (MAC protocol)
10/2006
1Therapeutics
10/2006